Alembic Pharmaceuticals Statistics

Total Valuation

BOM:533573 has a market cap or net worth of INR 137.26 billion. The enterprise value is 150.68 billion.

Market Cap	137.26B
Enterprise Value	150.68B

Important Dates

The last earnings date was Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	Jul 29, 2025

Share Statistics

Current Share Class	196.56M
Shares Outstanding	n/a
Shares Change (YoY)	-0.41%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	5.53%
Owned by Institutions (%)	17.32%
Float	57.86M

Valuation Ratios

The trailing PE ratio is 21.82 and the forward PE ratio is 17.17.

PE Ratio	21.82
Forward PE	17.17
PS Ratio	1.89
PB Ratio	2.58
P/TBV Ratio	2.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	23.96
EV / Sales	2.07
EV / EBITDA	13.16
EV / EBIT	17.48
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.28
Debt / EBITDA	1.30
Debt / FCF	n/a
Interest Coverage	9.03

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	10.58%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	4.39M
Profits Per Employee	379,555
Employee Count	16,571
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:533573 has paid 1.41 billion in taxes.

Income Tax	1.41B
Effective Tax Rate	18.42%

Stock Price Statistics

The stock price has decreased by -6.19% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.19%
50-Day Moving Average	789.12
200-Day Moving Average	909.37
Relative Strength Index (RSI)	21.15
Average Volume (20 Days)	3,364

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:533573 had revenue of INR 72.67 billion and earned 6.29 billion in profits. Earnings per share was 32.07.

Revenue	72.67B
Gross Profit	51.96B
Operating Income	8.64B
Pretax Income	7.67B
Net Income	6.29B
EBITDA	11.27B
EBIT	8.64B
Earnings Per Share (EPS)	32.07

Full Income Statement

Balance Sheet

The company has 1.43 billion in cash and 14.89 billion in debt, giving a net cash position of -13.46 billion.

Cash & Cash Equivalents	1.43B
Total Debt	14.89B
Net Cash	-13.46B
Net Cash Per Share	n/a
Equity (Book Value)	53.16B
Book Value Per Share	270.70
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.51%, with operating and profit margins of 11.88% and 8.66%.

Gross Margin	71.51%
Operating Margin	11.88%
Pretax Margin	10.56%
Profit Margin	8.66%
EBITDA Margin	15.51%
EBIT Margin	11.88%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.56%.

Dividend Per Share	11.00
Dividend Yield	1.56%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.41%
Shareholder Yield	1.97%
Earnings Yield	4.58%
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1